Hydroxyurea enhanced fetal hemoglobin production in sickle cell anemia

O. S. Platt, S. H. Orkin, G. Dover

Research output: Contribution to journalArticlepeer-review

361 Scopus citations


Hydroxyurea, a widely used cytotoxic/cytostatic agent that does not influence methylation of DNA bases, increases fetal hemoglobin production in anemic monkeys. To determine its effect in sickle cell anemia, we treated two patients with a total of four, 5-d courses (50 mg/kg per d, divided into three oral doses). With each course, fetal reticulocytes increased within 48-72 h, peaked in 7-11 d, and fell by 18-21 d. In patient I, fetal reticulocytes increased from 16.0 ± 2.0% to peaks of 37.7 ± 1.2, 40.0 ± 2.0, and 32.0 ± 1.4% in three successive courses. In patient II the increase was from 8.7 ± 1.2 to 50.0 ± 2.0%. Fetal hemoglobin increased from 7.9 to 12.3% in patient I and from 5.3 to 7.4% in patient II. Hemoglobin of patient I increased from 9.0 to 10.5 g/dl and in patient II from 6.7 to 9.9 g/dl. Additional single-day courses of hydroxyurea every 7-20 d maintained the fetal hemoglobin of patient I at 10.8-14.4%, and the total hemoglobin at 8.7-10.8 g/dl for an additional 60 d. The lowest absolute granulocyte count was 1,600/mm3; the lowest platelet count was 390,000/mm3. The amount of fetal hemoglobin per erythroid burst colony-forming unit (BFU-E)-derived colony cell was unchanged, but the number of cells per BFU-E-derived colony increased. Although examination of DNA synthesis in erythroid marrow cells in vitro revealed no decreased methylcytidine incorporation, Eco RI + Hpa II digestion of DNA revealed that hypomethylation of gamma-genes had taken place in vivo after treatment. This observation suggests that hydoxyurea is a potentially useful agent for the treatment of sickle cell anemia and that demethylation of the gamma-globin genes accompanies increased gamma-globin gene activity.

Original languageEnglish (US)
Pages (from-to)652-656
Number of pages5
JournalJournal of Clinical Investigation
Issue number2
StatePublished - 1984
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Hydroxyurea enhanced fetal hemoglobin production in sickle cell anemia'. Together they form a unique fingerprint.

Cite this